November 01, 2017

Biocomplexity Institute Hosts Research Symposium and Data Center Ribbon-Cutting

The 2017 Research Symposium on November 8 will feature groundbreaking discussions, poster sessions, and networking with top researchers—register now to attend or livestream the event on Facebook.

October 27, 2017

Research Team Creates Powerful System to Identify Biological Threats

The Functional Genomic and Computational Assessment of Threats program challenges scientists to develop new approaches for screening genetic information for evidence of a potentially harmful biological agent.

October 26, 2017

Virginia Tech Scientists Share Research at Virginia Academy of Science, Engineering, and Medicine

Virginia Tech leaders, scientists, and engineers will gather Oct. 29-30 to focus on challenges in emerging infections and preparedness for the 2017 Summit of the Virginia Academy of Science, Engineering, and Medicine (VASEM). 

October 10, 2017

Biocomplexity Institute Launches Campaign to Fight Breast Cancer’s Overwhelming Impact in Appalachia

This Breast Cancer Awareness Month, Biocomplexity Institute volunteers have launched a campaign to send free mammograms to local communities in need. You can help by contributing today at 

October 05, 2017

Top Researchers Convening to Explore Evidence That Could Change the Way Science Looks at DNA

The Biocomplexity Institute will host a ground-breaking symposium, “Beyond Sequence Alignment,” October 16-17, 2017, to further investigate the possibilities of developing new sequence-to-structure analytics. Leading-edge scientists from across the country will gather to analyze new ways to assess information contained in DNA sequences.

September 29, 2017

Lab Director Raises $10 Million to Launch Private Development of Therapeutics for Autoimmune Disease

Biocomplexity Institute Lab Director Josep Bassaganya-Riera announced a successful round of Series A funding for his privately established biotherapeutics company. Landos Biopharma Inc. will develop treatments for Crohn’s disease and ulcerative colitis that could bring relief to the approximately 1.6 million American and 4 million global sufferers of IBD. 

See All News